Pharmacological evaluation of 3-(N-3,3-diphenylpropyl-N-methyl)-aminopropan-1-ol-hydrochloride (PF-82), a new type of antidepressant drug.
D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D002415:Cats; D002642:Chick Embryo; D004285:Dogs; D004336:Drug Antagonism; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004569:Electroencephalography; D005260:Female; D006168:Guinea Pigs; D000882:Haplorhini; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology; D051379:Mice; D008995:Monoamine Oxidase / Q000378:metabolism; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D009904:Optical Rotation; D011412:Propanolamines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy
D000928:Antidepressive Agents; D011412:Propanolamines; D000639:Amitriptyline; D008694:Methamphetamine; D012110:Reserpine; D008995:Monoamine Oxidase; D007099:Imipramine; D009638:Norepinephrine